Baolingbao and Fengli Jingqiu reached a strategic cooperation. On December 11th, Baolingbao Biological Co., Ltd. (referred to as "Baolingbao") and Beijing Fengli Jingqiu Pharmaceutical Co., Ltd. (referred to as "Fengli Jingqiu") formally signed an agreement to start the strategic cooperation of lactulose bulk drug products. The two sides will carry out global technology and market expansion in the field of pharmaceutical raw materials.China, a brokerage firm: It has become the gold standard for hot money and private placement to choose stocks. The speculation in the stock market, especially for Public Offering of Fund's low rights issue, has almost become the gold standard for hot money and private placement. The market speculation on the food track driven by Yiming Food is, to a certain extent, just a theme pull to avoid the fund's heavy stocks, that is, on the one hand, the hot money can't pull the varieties with large market value and fundamental support, on the other hand, the hot money can't pull the stock price crazily under the background of a large number of heavy stocks of Public Offering of Fund products. "If a public offering finds that the stocks it holds suddenly go up like crazy for no reason, the first reaction is to sell them, and the higher they go up, the more they sell. Therefore, the stocks selected by the hot money speculation market usually don't choose companies with reliable fundamentals, because such companies have heavy positions in Public Offering of Fund products in most cases." A research director of a fund company in Shenzhen explained the speculation logic of the current stock market. (Broker China)Changchuan Technology has invested in Keweisheng, a visual software developer. According to the company's search APP, recently, Keweisheng Visual Technology (Suzhou) Co., Ltd. has undergone industrial and commercial changes, and the new growth Sichuan Technology is the major shareholder, holding 51% of the shares. Enterprise information shows that the company was established in 2015, with Tian Zhifeng as its legal representative and a registered capital of 10 million yuan, and its business scope includes visual technology development. According to its official website, Keweisheng is an enterprise specializing in the development of visual software and hardware solutions.
Central Bank: On December 18th, 20 billion yuan of central bank bills will be issued. On December 18th, the People's Bank of China will issue the 12th issue of central bank bills in 2024 through the CMU bond bidding platform of the Hong Kong Monetary Authority. The 12th central bank bill has a maturity of 6 months (182 days), and is a fixed-rate interest-bearing bond, with a circulation of RMB 20 billion. The value date is December 20, 2024, and the maturity date is June 20, 2025, and the maturity date will be postponed in case of a holiday.Xinwei International (00058.HK) once rose by 90% when it resumed trading, but now the increase has narrowed to less than 50%.The net outflow of the main market exceeded 10 billion.
Baolingbao and Fengli Jingqiu reached a strategic cooperation. On December 11th, Baolingbao Biological Co., Ltd. (referred to as "Baolingbao") and Beijing Fengli Jingqiu Pharmaceutical Co., Ltd. (referred to as "Fengli Jingqiu") formally signed an agreement to start the strategic cooperation of lactulose bulk drug products. The two sides will carry out global technology and market expansion in the field of pharmaceutical raw materials.FTSE China A50 index futures opened 0.13% higher, and closed down 0.01% in the last session.Ordinary people invested in the establishment of a Chinese medicine comprehensive clinic company. The enterprise search APP shows that Yangzhong Ordinary People Chinese Medicine Comprehensive Clinic Co., Ltd. was recently established, with lin li as the legal representative and a registered capital of 100,000 yuan. Its business scope includes: drug retail; Chinese medicine clinic service. Enterprise investigation shows that the company is indirectly wholly owned by ordinary people.
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
Strategy guide 12-13
Strategy guide
12-13
Strategy guide 12-13